Phase 3 randomized COMMODORE 1 trial: Crovalimab versus eculizumab in complement inhibitor‐experienced patients with paroxysmal nocturnal hemoglobinuria

Phillip Scheinberg, Austin Kulasekararaj, Sasha Sreckovic et al.|American Journal of Hematology|2024

Cited by 42